PAVM Live signals | Maximize Profits with Getagraph.com

Live Chart Being Loaded With Signals

Commentary (19 Apr 2024 @ 16:00):

Stats
Today's Volume	19 849.00
Average Volume	63 276.00
Market Cap	17.06M
EPS	$-1.810 ( 2024-03-26 )
Next earnings date	( $-1.670 ) 2024-05-21
Last Dividend	$0 ( N/A )
Next Dividend	$0 ( N/A )
P/E	-0.200
ATR14	$0.0210 (1.14%)

Insider Trading

Date	Person	Action	Amount	type
2024-02-22	Baxter Timothy E	Buy	65 000	Common stock
2024-02-22	White Debra	Buy	65 000	Common stock
2024-02-22	Sparks Ronald M	Buy	65 000	Common stock
2024-02-22	Harvey Joan B	Buy	65 000	Common stock
2024-02-22	Glennon Michael J	Buy	65 000	Common stock

INSIDER POWER
99.86
Last 94 transactions
Buy: 11 877 994 \| Sell: 5 035 719

Volume Correlation

Long: 0.00 (neutral)

Short: -0.86 (strong negative)

Signal:(40.725) Neutral

PAVmed Inc Correlation

10 Most Positive Correlations

10 Most Negative Correlations

Did You Know?

Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).

Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.

PAVmed Inc Correlation - Currency/Commodity

0.57
( weak )

0.64
( weak )

0.00
( neutral )

0.68
( moderate )

-0.29
( neutral )

-0.78
( moderate negative )

PAVmed Inc Financials

Annual	2023
Revenue:	$2.45M
Gross Profit:	$-6.90M (-281.40 %)
EPS:	$-8.87

Q4	2023
Revenue:	$1.05M
Gross Profit:	$-1.29M (-122.69 %)
EPS:	$-1.710

Q3	2023
Revenue:	$791 000
Gross Profit:	$-988 000 (-124.91 %)
EPS:	$-2.38

Q2	2023
Revenue:	$166 000
Gross Profit:	$-1.52M (-915.06 %)
EPS:	$-2.09

Financial Reports:

No articles found.

PAVmed Inc

PAVmed Inc. operates as a medical device company in the United States. The company's lead products include CarpX, a percutaneous device to treat carpal tunnel syndrome; and EsoCheck, an esophageal cell collection device for the early detection of adenocarcinoma of the esophagus and Barrett's Esophagus (BE); and EsoGuard, a bisulfite-converted next-generation sequencing DNA assay. Its product pipeline also comprises EsoCure, an esophageal ablation device to treat dysplastic BE; PortIO, an implantable intraosseous vascular access device; NextFlo, a disposable infusion platform technology; Veris cancer healthcare platform and implantable intelligent vascular port combining remote monitoring and data analytics; NextVent single-use ventilators; FlexMO medical circulatory support cannulas; Veris cardiac monitors; DisappEAR resorbable pediatric ear tubes; Solys noninvasive glucose monitoring. The company was formerly known as PAXmed Inc. and changed its name to PAVmed Inc. in April 2015. PAVmed Inc. was incorporated in 2014 and is headquartered in New York, New York.